Article Information
History
- March 17, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Vivek Shankar1,†,
- Xiaoli Yang2,†,
- Vrishab Krishna1,†,
- Brent T. Tan, MD PhD3,
- Oscar Silva, MD PhD3,
- Rebecca Rojansky, MD PhD3,
- Andrew Y. Ng, PhD1,
- Fabiola Valvert, MD5,
- Edward L. Briercheck, MD PhD6,
- David M. Weinstock, MD PhD7,8,
- Yasodha Natkunam, MD PhD3,
- Sebastian Fernandez-Pol, MD PhD3,+,‡ and
- Pranav Rajpurkar, PhD4,+,‡
- 1Department of Computer Science, Stanford University, Stanford, United States
- 2Department of Statistics, Stanford University, Stanford, United States
- 3Department of Pathology, Stanford University School of Medicine, Stanford, United States
- 4Department of Biomedical Informatics, Harvard Medical School, Boston, United States
- 5Laboratorio de Investigación Biológica en Cancer, Liga Nacional contra el Cancer/ Instituto de Cancerología, Guatemala
- 6Fred Hutchinson Cancer Research Center and the University of Washington
- 7Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States
- 8Merck Research Laboratory
- ↵+Corresponding author:
Correspondence to Pranav Rajpurkar (pranav_rajpurkar{at}hms.harvard.edu) and Sebastian Fernandez-Pol (sfernand{at}stanford.edu)
↵† These authors contributed equally: Vivek Shankar, Xiaoli Yang, Vrishab Krishna.
‡ These authors contributed equally: Sebastian Fernandez-Pol, Pranav Rajpurkar.
Posted March 17, 2023.
LymphoML: An interpretable artificial intelligence-based method identifies morphologic features that correlate with lymphoma subtype
